1. Home
  2. PGC vs ZVRA Comparison

PGC vs ZVRA Comparison

Compare PGC & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peapack-Gladstone Financial Corporation

PGC

Peapack-Gladstone Financial Corporation

SELL

Current Price

$43.26

Market Cap

769.6M

Sector

Finance

ML Signal

SELL

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

SELL

Current Price

$10.32

Market Cap

689.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PGC
ZVRA
Founded
1921
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
769.6M
689.4M
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
PGC
ZVRA
Price
$43.26
$10.32
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
★ $56.00
$25.00
AVG Volume (30 Days)
113.0K
★ 849.5K
Earning Date
11-06-2026
11-04-2026
Dividend Yield
★ 0.46%
N/A
EPS Growth
13.51
★ 159.21
EPS
★ 1.65
0.74
Revenue
★ $282,995,000.00
$106,470,000.00
Revenue This Year
$24.36
$43.97
Revenue Next Year
$12.76
$15.93
P/E Ratio
$26.42
★ $15.30
Revenue Growth
24.05
★ 350.91
52 Week Low
$24.71
$8.01
52 Week High
$49.14
$15.04

Technical Indicators

Market Signals
Indicator
PGC
ZVRA
Relative Strength Index (RSI) 37.71 39.50
Support Level $42.23 $10.07
Resistance Level $44.07 $11.07
Average True Range (ATR) 0.89 0.48
MACD -0.07 0.01
Stochastic Oscillator 33.77 34.14

Price Performance

Historical Comparison
PGC
ZVRA

About PGC Peapack-Gladstone Financial Corporation

Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: